Oxytocin Market Size, Share, Opportunities, And Trends By Indication (Antepartum, Postpartum), By Distribution Channel (Offline, Online), And By Geography - Forecasts From 2025 To 2030

Description

Oxytocin Market Size:

The Oxytocin Market is anticipated to grow from USD 122.490 million in 2025 to USD 157.078 million by 2030, registering a 5.10% CAGR.

Oxytocin is a hormone that is given to women during pregnancy generally when there are childbirth complications in order to induce labor or support and make the uterine contractions strong. The prevalence of childbirth complications has been increasing over the years and is expected to propel the growth of the oxytocin market during the forecast period. Furthermore, the increasing access to hospitals and medical facilities is leading to a higher number of women giving birth in hospitals now, which is further expected to boost the market growth of oxytocin during the assessment period. However, the partial ban on oxytocin by various countries is projected to hamper the market growth in the coming years.

Oxytocin Market Growth Drivers:

• Growing cases of childbirth complications

The cases of childbirth complications have been increasing over the years and are projected to continue growing in the coming years as well, which is anticipated to bolster the growth of the oxytocin market during the forecast period, as the medicine is widely used in childbirth complications. The Blue Cross Blue Shield Association states that women with pregnancy complications have twice the chance of having childbirth complications as well. As per the report titled "Trends in Pregnancy and Childbirth Complications in the U.S." published in June 2020, pregnancy complications have increased by 16.4% and childbirth complications have increased from 14.2% during the period from 2014 to 2018. The childbirth complication with the highest growth between 2014 and 2018 was eclampsia, as per the Blue Cross Blue Shield Association. The prevalence rate of eclampsia in the United States has increased from 1.1 per 1,000 cases to 1.7 per 1,000 cases, witnessing a growth of 57.9% between 2014 and 2018. Other complications such as cardiomyopathy, embolism, sepsis, and respiratory distress have also been witnessing growth in their prevalence. The growing cases of childbirth complications are leading to an increased need for oxytocin to induce labor or strengthen uterine contractions, or control bleeding after childbirth. The growing trend of childbirth defects is expected to continue supplementing the market growth of oxytocin during the forecast period.

Oxytocin Market Geographical Outlook:

• North America to hold a significant market share

Geographically, the North American region is anticipated to hold a significant market share owing to the presence of an advanced healthcare system and high awareness in the region regarding pregnancy and childbirth complications. The Asia Pacific region is anticipated to witness substantial growth due to increasing access to medical facilities for pregnant women.

List of Top Oxytocin Companies:

• Viatris Inc.
• Pfizer Inc.
• Taj Pharmaceuticals Ltd.
• KAPL
• Bimeda

Oxytocin Market Scope:

Segmentation

• By Indication
  • Antepartum Hemorrhage
  • Postpartum Hemorrhage (PPH)
  • Labor Induction
  • Uterine Atony
  • Miscarriage Management
  • Lactation Support
• By Dosage Form
  • Injection
  • Nasal Spray
  • Other Forms
• By End-User
  • Hospitals
  • Maternity Clinics
  • Home Birth Settings
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Others

Navigation

• Oxytocin Market Size:
• Oxytocin Market Key Highlights:
• Oxytocin Market Growth Drivers:
• Oxytocin Market Geographical Outlook:
• List of Top Oxytocin Companies:
• Oxytocin Market Scope:

Table Of Contents

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. OXYTOCIN MARKET BY INDICATION

5.1. Introduction

5.2. Antepartum Hemorrhage

5.3. Postpartum Hemorrhage (PPH)

5.4. Labor Induction

5.5. Uterine Atony

5.6. Miscarriage Management

5.7. Lactation Support

6. OXYTOCIN MARKET BY DOSAGE FORM

6.1. Introduction

6.2. Injection

6.3. Nasal Spray

6.4. Other Forms

7. OXYTOCIN MARKET BY END-USER

7.1. Introduction

7.2. Hospitals

7.3. Maternity Clinics

7.4. Home Birth Settings

8. OXYTOCIN MARKET BY DISTRIBUTION CHANNEL

8.1. Introduction

8.2. Hospital Pharmacies

8.3. Retail Pharmacies

8.4. Online Pharmacies

8.5. Others

9. OXYTOCIN MARKET BY GEOGRAPHY

9.1. Introduction

9.2. North America

9.2.1. By Indication

9.2.2. By Dosage Form

9.2.3. By End-User

9.2.4. By Distribution Channel

9.2.5. By Country

9.2.5.1. USA

9.2.5.2. Canada

9.2.5.3. Mexico

9.3. South America

9.3.1. By Indication

9.3.2. By Dosage Form

9.3.3. By End-User

9.3.4. By Distribution Channel

9.3.5. By Country

9.3.5.1. Brazil

9.3.5.2. Argentina

9.3.5.3. Others

9.4. Europe

9.4.1. By Indication

9.4.2. By Dosage Form

9.4.3. By End-User

9.4.4. By Distribution Channel

9.4.5. By Country

9.4.5.1. United Kingdom

9.4.5.2. Germany

9.4.5.3. France

9.4.5.4. Spain

9.4.5.5. Others

9.5. Middle East and Africa

9.5.1. By Indication

9.5.2. By Dosage Form

9.5.3. By End-User

9.5.4. By Distribution Channel

9.5.5. By Country

9.5.5.1. Saudi Arabia

9.5.5.2. UAE

9.5.5.3. Others

9.6. Asia Pacific

9.6.1. By Indication

9.6.2. By Dosage Form

9.6.3. By End-User

9.6.4. By Distribution Channel

9.6.5. By Country

9.6.5.1. China

9.6.5.2. Japan

9.6.5.3. India

9.6.5.4. South Korea

9.6.5.5. Taiwan

9.6.5.6. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Competitive Dashboard

11. COMPANY PROFILES

11.1. Pfizer Inc.

11.2. Merck & Co., Inc.

11.3. GlaxoSmithKline plc

11.4. Grindeks

11.5. Taj Pharmaceuticals Ltd.

11.6. Karnataka Antibiotics & Pharmaceuticals Ltd. (KAPL)

12. APPENDIX

12.1. Currency

12.2. Assumptions

12.3. Base and Forecast Years Timeline

12.4. Key benefits for the stakeholders

12.5. Research Methodology 

12.6. Abbreviations 

LIST OF FIGURES

LIST OF TABLES

Companies Profiled

Pfizer Inc.

Merck & Co., Inc.

GlaxoSmithKline plc

Grindeks

Taj Pharmaceuticals Ltd.

Karnataka Antibiotics & Pharmaceuticals Ltd. (KAPL)

Related Reports